glp-1 and diabetes GLP-1-based therapies for type 2 diabetes: from single, dual triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Is GLP-1 the Same as

While the drug is approved for type 2 diabetes management and cardiovascular risk reduction in high-risk patients with diabetes, it contains the same active ingredient (semaglutide) as Wegovy, but costs less than the injection

Referral Process: see referral guidelines section M.A , S.S & A.C 09-04-26 Who to refer: Refer the following patients to the Lets Prevent Diabetes Programme: Pre-diabetes : Refer patients withPre-diabetes (HbA1C 42 47, impaired fasting glucose, impaired glucose tolerance), or patients who are at high risk of developing diabetes for other reasons (see primary care management tab for risk stratification)

Research indicates that GLP-1RAs can ameliorate hepatic steatosis by regulating lipid synthesis pathways and enhancing fatty acid oxidation

Every person evaluating any compounded GLP-1 program - IVY RX included - should understand this before enrolling